{"id":"placebo-for-metformin","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebos are inert substances used as controls in clinical trials to measure the effect of patient expectation and the natural disease course independent of active drug treatment. In this case, it serves as a comparator to metformin in a clinical study conducted at Seoul National University Hospital. Any observed benefits result from placebo effect, regression to the mean, or natural disease progression rather than from the substance itself.","oneSentence":"A placebo has no active pharmacological mechanism; it produces therapeutic effects through psychological and physiological expectation rather than direct drug action.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:36:09.692Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control comparator in metformin clinical trial"}]},"trialDetails":[{"nctId":"NCT02122185","phase":"PHASE2","title":"Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2015-02-25","conditions":"Brenner Tumor, Malignant Ascites, Malignant Pleural Effusion","enrollment":111},{"nctId":"NCT07485764","phase":"PHASE4","title":"Metformin Combined With Secukinumab for Moderate-to-Severe Plaque Psoriasis in Overweight or Obese Chinese Patients","status":"NOT_YET_RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2026-06","conditions":"Psoriasis, Plaque Psoriasis, Moderate-to-severe Plaque Psoriasis","enrollment":186},{"nctId":"NCT05013112","phase":"NA","title":"Ameliorating Metabolic Profiling After Kidney Transplantation (AMPKT)","status":"COMPLETED","sponsor":"West China Hospital","startDate":"2023-01-01","conditions":"Kidney Transplantation, Metabolic Disorder, Metformin","enrollment":105},{"nctId":"NCT07045142","phase":"PHASE3","title":"Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients","status":"RECRUITING","sponsor":"Central South University","startDate":"2025-07-01","conditions":"Schizophrenia","enrollment":400},{"nctId":"NCT07475546","phase":"PHASE3","title":"Combination Gerotherapeutic Interventions for Healthspan Improvement","status":"ACTIVE_NOT_RECRUITING","sponsor":"AgelessRx","startDate":"2025-07-23","conditions":"Healthspan Improvement, Aging, Longevity","enrollment":30},{"nctId":"NCT01351753","phase":"PHASE2","title":"Drug Therapy Induced Weight Loss to Improve Blood Vessel Function in Subjects With Obesity","status":"TERMINATED","sponsor":"University of Iowa","startDate":"2011-03","conditions":"Obesity, Metabolic Syndrome X","enrollment":128},{"nctId":"NCT04596631","phase":"PHASE3","title":"A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2020-11-02","conditions":"Diabetes Mellitus, Type 2","enrollment":132},{"nctId":"NCT05279768","phase":"PHASE1, PHASE2","title":"Stem Cells and Secretomes for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance.","status":"COMPLETED","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2022-09-01","conditions":"Polycystic Ovary Syndrome","enrollment":44},{"nctId":"NCT06611501","phase":"PHASE2","title":"Glycemic Regulation as Endometriosis Adjunct Treatment","status":"RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2025-05-22","conditions":"Pelvic Pain, Endometriosis","enrollment":14},{"nctId":"NCT05900284","phase":"PHASE2","title":"Safety and Feasibility of Metformin for Sepsis Induced AKI","status":"ENROLLING_BY_INVITATION","sponsor":"Hernando Gomez","startDate":"2023-11-08","conditions":"Sepsis, Septic Shock, Acute Kidney Injury","enrollment":80},{"nctId":"NCT04850846","phase":"PHASE2","title":"Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2021-04-27","conditions":"Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma","enrollment":60},{"nctId":"NCT06961019","phase":"NA","title":"Clinical Study to Assess the Safety, Efficacy and In-Use Tolerability of Herbal-Based Sugar Support Effervescent Tablets in Type-2 Diabetes Mellitus Patients","status":"RECRUITING","sponsor":"NovoBliss Research Pvt Ltd","startDate":"2025-08-25","conditions":"Type2 Diabetes Mellitus","enrollment":14},{"nctId":"NCT06090227","phase":"PHASE1, PHASE2","title":"AMPK-activation by Metformin in FSGS: AMP-FSGS","status":"RECRUITING","sponsor":"Yale University","startDate":"2023-12-14","conditions":"Focal Segmental Glomerulosclerosis","enrollment":30},{"nctId":"NCT04341571","phase":"PHASE2","title":"Effect of Probiotics Versus Metformin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Prediabetes.","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Guadalajara","startDate":"2019-10-24","conditions":"PreDiabetes, Impaired Glucose Tolerance, Hyperglycemia","enrollment":30},{"nctId":"NCT05230758","phase":"PHASE3","title":"Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour","status":"RECRUITING","sponsor":"Donald Mabbott","startDate":"2022-07-01","conditions":"Medulloblastoma, Childhood, Cognitive Impairment","enrollment":140},{"nctId":"NCT06065540","phase":"PHASE3","title":"A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2023-09-27","conditions":"Type 2 Diabetes Mellitus","enrollment":2734},{"nctId":"NCT06273072","phase":"PHASE2","title":"Metformin IN Asthma for Overweight and Obese Individuals (MINA)","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2024-12-09","conditions":"Asthma, Asthma Chronic, Overweight and Obesity","enrollment":100},{"nctId":"NCT03862950","phase":"PHASE2","title":"A Trial of Metformin in Individuals With Fragile X Syndrome (Met)","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2019-05-24","conditions":"Fragile X Syndrome, Fragile X Mental Retardation Syndrome, Mental Retardation, X-Linked","enrollment":125},{"nctId":"NCT00971243","phase":"PHASE2","title":"Efficacy and Safety of MP-513 in Combination With Metformin in Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"Tanabe Pharma Corporation","startDate":"2009-08","conditions":"Type 2 Diabetes Mellitus","enrollment":448},{"nctId":"NCT05093959","phase":"PHASE2","title":"Metformin for Older Patients With Heart Failure With Preserved Ejection Fraction","status":"ACTIVE_NOT_RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2022-01-04","conditions":"Heart Failure With Preserved Ejection Fraction","enrollment":86},{"nctId":"NCT07321223","phase":"NA","title":"Comparison of Different Doses of Vitamin D Supplementation on Glycated Haemoglobin and Blood Glucose Parameters With Type II Diabetes Mellitus Having Vitamin d Deficiency","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Lahore","startDate":"2024-08-22","conditions":"Diabetes (DM), Vitamin D Deficiency","enrollment":108},{"nctId":"NCT02924064","phase":"PHASE3","title":"Efficacy and Safety of Teneligliptin in Combination With Metformin in Chinese Patients With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Tanabe Pharma Corporation","startDate":"2016-09","conditions":"Type 2 Diabetes Mellitus","enrollment":247},{"nctId":"NCT07303127","phase":"NA","title":"Combination of Bitter Melon Extract and Snakehead Fish Powder to Reduce Glycaemia in Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Universitas Muhammadiyah Surakarta","startDate":"2021-06-01","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":80},{"nctId":"NCT06526494","phase":"PHASE2","title":"Metformin and Vascular Function in Prediabetes","status":"WITHDRAWN","sponsor":"Diana Jalal","startDate":"2024-11-13","conditions":"PreDiabetes","enrollment":""},{"nctId":"NCT07302932","phase":"NA","title":"Metformin and Molecular Aging in Prediabetes","status":"COMPLETED","sponsor":"Diabetes Foundation, India","startDate":"2023-02-01","conditions":"Metformin, Prediabetes","enrollment":112},{"nctId":"NCT05838573","phase":"PHASE3","title":"Metformin Treatment on Cognitive Impairment of Schizophrenia","status":"RECRUITING","sponsor":"Central South University","startDate":"2023-05-08","conditions":"Schizophrenia","enrollment":120},{"nctId":"NCT06638671","phase":"PHASE4","title":"Short-Term Metformin Use in Young, Healthy Adults: Impacts on Exercise Capacity","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2025-01-31","conditions":"Exercise Capacity, Metformin","enrollment":20},{"nctId":"NCT07057479","phase":"PHASE3","title":"Phase III Trial of SGLT2 Inhibitor and Thiazolidinedione Fixed-Dose Combination vs. Monotherapy in Type 2 Diabetes Patients on Metformin","status":"WITHDRAWN","sponsor":"Eurofarma Laboratorios S.A.","startDate":"2026-09","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":""},{"nctId":"NCT06560333","phase":"PHASE3","title":"iSGLT2 Inhibitor and a iDPP -4 Inhibitor in Treatment of Type 2 Diabetes Mellitus in Patients Treated With Metformin (TRIAD)","status":"WITHDRAWN","sponsor":"Eurofarma Laboratorios S.A.","startDate":"2026-11-30","conditions":"Diabetes Mellitus, Type 2","enrollment":""},{"nctId":"NCT02915198","phase":"PHASE4","title":"Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2023-04-03","conditions":"Prediabetic State, Atherosclerosis, Metformin","enrollment":7410},{"nctId":"NCT06424860","phase":"PHASE1","title":"Fish Oil, Metformin and Heart Health in PCOS","status":"RECRUITING","sponsor":"University of Alberta","startDate":"2025-11-01","conditions":"PCOS, Cardiovascular Disease, Atherosclerotic Cardiovascular Disease","enrollment":146},{"nctId":"NCT05131828","phase":"PHASE2","title":"CCMR Two: A Phase IIa, Randomised, Double-blind, Placebo-controlled Trial of the Ability of the Combination of Metformin and Clemastine to Promote Remyelination in People With Relapsing-remitting Multiple Sclerosis Already on Disease-modifying Therapy","status":"COMPLETED","sponsor":"Cambridge University Hospitals NHS Foundation Trust","startDate":"2022-03-08","conditions":"Multiple Sclerosis","enrollment":70},{"nctId":"NCT03109847","phase":"PHASE2","title":"Metformin to Mitigate Sequelae of Radioactive Iodine Treatment for Thyroid Cancers","status":"TERMINATED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","startDate":"2017-01-05","conditions":"Thyroid","enrollment":13},{"nctId":"NCT06983223","phase":"NA","title":"Oral Sucrosomial® Vitamin B12 in the Management of B12 Deficiency Among Metformin-Treated Type 2 Diabetes Patients","status":"COMPLETED","sponsor":"Liaquat University of Medical & Health Sciences","startDate":"2025-08-15","conditions":"Vitamin B 12 Deficiency, Type 2 Diabetes Mellitus (T2DM)","enrollment":50},{"nctId":"NCT06185179","phase":"EARLY_PHASE1","title":"Metformin and Muscle Recovery","status":"RECRUITING","sponsor":"University of Utah","startDate":"2024-09-01","conditions":"Muscle Atrophy or Weakness","enrollment":50},{"nctId":"NCT06280274","phase":"PHASE4","title":"Metformin Use in Patients Undergoing Total Joint Replacement Surgery","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2024-06-27","conditions":"Hyperglycemia","enrollment":40},{"nctId":"NCT06323161","phase":"PHASE3","title":"A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Once-daily Basal Insulin With or Without Metformin","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2024-03-26","conditions":"Type 2 Diabetes","enrollment":274},{"nctId":"NCT05426044","phase":"PHASE2","title":"Metformin as a Neuroprotective Therapy for Glaucoma","status":"RECRUITING","sponsor":"Christopher Kai Shun Leung","startDate":"2025-06-01","conditions":"Glaucoma","enrollment":125},{"nctId":"NCT04578652","phase":"PHASE3","title":"Fiber and Metformin Combination Therapy in Adolescents With Severe Obesity and Insulin Resistance","status":"RECRUITING","sponsor":"University of Alberta","startDate":"2021-10-22","conditions":"Obesity, Childhood, Insulin Resistance","enrollment":90},{"nctId":"NCT04885530","phase":"PHASE3","title":"ACTIV-6: COVID-19 Study of Repurposed Medications","status":"COMPLETED","sponsor":"Susanna Naggie, MD","startDate":"2021-06-08","conditions":"Covid19","enrollment":10956},{"nctId":"NCT03229057","phase":"PHASE3","title":"Comparing the Effects of Oral Contraceptive Pills Versus Metformin","status":"COMPLETED","sponsor":"Anuja Dokras","startDate":"2018-01-15","conditions":"PCOS","enrollment":240},{"nctId":"NCT04029480","phase":"PHASE3","title":"Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2019-10-08","conditions":"Type 2 Diabetes Mellitus","enrollment":166},{"nctId":"NCT05237960","phase":"PHASE2","title":"Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Arizona","startDate":"2023-01-12","conditions":"Erythroplakia, Oral Leukoplakia","enrollment":34},{"nctId":"NCT04121468","phase":"PHASE1, PHASE2","title":"A Phase I Double Blind Study of Metformin Acting on Endogenous Neural Progenitor Cells in Children and Young Adults With Multiple Sclerosis","status":"RECRUITING","sponsor":"The Hospital for Sick Children","startDate":"2020-02-24","conditions":"Multiple Sclerosis (MS)","enrollment":20},{"nctId":"NCT03355469","phase":"PHASE2, PHASE3","title":"Exercise Dose and Metformin for Vascular Health in Metabolic Syndrome","status":"COMPLETED","sponsor":"Rutgers University","startDate":"2017-08-07","conditions":"Metabolic Syndrome","enrollment":91},{"nctId":"NCT03617458","phase":"PHASE2","title":"Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2018-08-23","conditions":"Pulmonary Artery Hypertension","enrollment":73},{"nctId":"NCT07179042","phase":"EARLY_PHASE1","title":"Intertrochanteric Femur Fracture Patients Who Receive Metformin With a Placebo","status":"ENROLLING_BY_INVITATION","sponsor":"University of Utah","startDate":"2025-09-04","conditions":"Intertrochanteric Femur Fracture, Muscle Atrophy","enrollment":60},{"nctId":"NCT07145827","phase":"NA","title":"Effect of Metformin on Endometrial Thickness in Postmenopausal Breast Cancer Patients Receiving Tamoxifen","status":"COMPLETED","sponsor":"Uruk University","startDate":"2024-01-02","conditions":"Breast Cancer, Endometrial Hyperplasia and Endometrial Cancers","enrollment":60},{"nctId":"NCT05132439","phase":"PHASE3","title":"MetfOrmin BenefIts Lower Extremities With Intermittent Claudication","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2022-03-01","conditions":"Intermittent Claudication","enrollment":200},{"nctId":"NCT03054519","phase":"PHASE3","title":"Improve PAD PERformance With METformin","status":"ACTIVE_NOT_RECRUITING","sponsor":"Northwestern University","startDate":"2017-05-23","conditions":"Peripheral Artery Disease","enrollment":203},{"nctId":"NCT07131384","phase":"NA","title":"Interaction Between Inorganic Nitrate Supplementation and Metformin in Individuals With Prediabetes","status":"NOT_YET_RECRUITING","sponsor":"University of Virginia","startDate":"2025-09-01","conditions":"Males, Females, Sedentary","enrollment":24},{"nctId":"NCT07093476","phase":"PHASE3","title":"Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and Metformin","status":"RECRUITING","sponsor":"Celltrion","startDate":"2025-07-18","conditions":"T2DM, Diabete Type 2, DM","enrollment":171},{"nctId":"NCT05243654","phase":"PHASE2","title":"Efficacy and Tolerability of Adjunct Metformin for Multibacillary Leprosy","status":"RECRUITING","sponsor":"Oxford University Clinical Research Unit Indonesia","startDate":"2022-10-01","conditions":"Leprosy, Leprosy, Multibacillary, Neglected Tropical Diseases","enrollment":166},{"nctId":"NCT02570672","phase":"PHASE2","title":"Metformin for Preventing Frailty in High-risk Older Adults","status":"COMPLETED","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2016-04","conditions":"Frailty","enrollment":141},{"nctId":"NCT05744479","phase":"PHASE4","title":"Metformin for Antipsychotic-induced Weight Gain in Adults With Intellectual Disability","status":"RECRUITING","sponsor":"Centre for Addiction and Mental Health","startDate":"2023-02-28","conditions":"Intellectual Disability, Developmental Disability, Obesity","enrollment":100},{"nctId":"NCT06649773","phase":"PHASE3","title":"The Experiment of Noiiglutide Injection in Type 2 Diabetes Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2024-10-25","conditions":"Type 2 Diabetes","enrollment":137},{"nctId":"NCT06481085","phase":"PHASE2","title":"To Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.","startDate":"2024-06-27","conditions":"Type 2 Diabetes","enrollment":324},{"nctId":"NCT06846138","phase":"NA","title":"Enhancing the Efficacy and Tolerability of Metformin by add-on Polyherbal Formulation: a Gut Microbiome Study","status":"ENROLLING_BY_INVITATION","sponsor":"Pauls Stradins Clinical University Hospital","startDate":"2025-03-01","conditions":"Diabetes Mellitus Type 2","enrollment":66},{"nctId":"NCT02040376","phase":"PHASE3","title":"Metformin for Brain Repair in Children With Cranial-Spinal Radiation for Medulloblastoma","status":"COMPLETED","sponsor":"The Hospital for Sick Children","startDate":"2014-06-13","conditions":"Brain Tumor Treated With Cranial or Cranial-Spinal Radiation","enrollment":24},{"nctId":"NCT01825798","phase":"PHASE3","title":"Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)","status":"COMPLETED","sponsor":"Holland Bloorview Kids Rehabilitation Hospital","startDate":"2013-04","conditions":"Overweight, Autism Spectrum Disorder","enrollment":60},{"nctId":"NCT07065591","phase":"EARLY_PHASE1","title":"Anti-Diabetic Drug, Exercise and Healthy Diet for Knee Osteoarthritis With Overweight/Obesity","status":"NOT_YET_RECRUITING","sponsor":"The University of Hong Kong","startDate":"2025-10-01","conditions":"Osteoarthritis (OA) of the Knee","enrollment":100},{"nctId":"NCT07055958","phase":"PHASE3","title":"Effect of Metformin as Add-on Therapy in Levodopa Treated Parkinson's Disease Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","startDate":"2024-12-29","conditions":"Parkinson Disease","enrollment":74},{"nctId":"NCT02500147","phase":"PHASE4","title":"Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)","status":"TERMINATED","sponsor":"Columbia University","startDate":"2011-09-08","conditions":"Polycystic Ovary Syndrome, Non-Alcoholic Fatty Liver Disease, Metabolic Syndrome","enrollment":3},{"nctId":"NCT04939935","phase":"PHASE3","title":"Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD)","status":"RECRUITING","sponsor":"The University of Queensland","startDate":"2022-11-29","conditions":"Autosomal Dominant Polycystic Kidney Disease","enrollment":1174},{"nctId":"NCT04207944","phase":"PHASE2","title":"The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Duke University","startDate":"2020-07-10","conditions":"IPMN, IPMN, Pancreatic","enrollment":100},{"nctId":"NCT01697566","phase":"PHASE3","title":"An Endometrial Cancer Chemoprevention Study of Metformin","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2013-05-30","conditions":"Gynecology","enrollment":29},{"nctId":"NCT03686657","phase":"PHASE1, PHASE2","title":"Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes Patients","status":"NOT_YET_RECRUITING","sponsor":"ARKAY Therapeutics","startDate":"2025-10-10","conditions":"Type 2 Diabetes, High Blood Pressure, Arthritis","enrollment":115},{"nctId":"NCT06999343","phase":"PHASE3","title":"Exploring the Anti-ageing Effects of Metformin in COPD","status":"NOT_YET_RECRUITING","sponsor":"Fundación Instituto de Investigación Sanitaria de Navarra","startDate":"2025-09-01","conditions":"COPD","enrollment":212},{"nctId":"NCT05917587","phase":"EARLY_PHASE1","title":"Metformin for the Treatment of Microvascular Dysfunction After Gestational Diabetes","status":"RECRUITING","sponsor":"Anna Stanhewicz, PhD","startDate":"2024-09-11","conditions":"Gestational Diabetes","enrollment":30},{"nctId":"NCT06965868","phase":"NA","title":"Role of the Blood-Brain Barrier in Stress Resilience: Investigating New Pathways Towards Pharmacological Augmentation of Stress Resilience","status":"NOT_YET_RECRUITING","sponsor":"Leibniz-Institut für Resilienzforschung (LIR) gGmbH","startDate":"2025-06","conditions":"Stress Resilience, Blood-Brain Barrier Integrity, Mental Health","enrollment":122},{"nctId":"NCT04264897","phase":"PHASE3","title":"Antecedent Metabolic Health and Metformin Aging Study","status":"COMPLETED","sponsor":"Oklahoma Medical Research Foundation","startDate":"2020-07-29","conditions":"Aging, Insulin Sensitivity, Chronic Disease","enrollment":101},{"nctId":"NCT03109873","phase":"EARLY_PHASE1","title":"Metformin Hydrochloride in Affecting Cytokines and Exosomes in Patients With Head and Neck Cancer","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","startDate":"2017-01-05","conditions":"Larynx, Lip, Oral Cavity","enrollment":9},{"nctId":"NCT05900466","phase":"PHASE2","title":"Metformin for Fibromyalgia Symptoms (INFORM Trial)","status":"RECRUITING","sponsor":"University of Utah","startDate":"2023-04-01","conditions":"Fibromyalgia Syndrome","enrollment":72},{"nctId":"NCT06096259","phase":"PHASE2","title":"Preventing Injured Knees From osteoArthritis: Severity Outcomes","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2024-05-06","conditions":"Osteoarthritis, Knee, Post-traumatic Osteoarthritis, ACL Tear","enrollment":512},{"nctId":"NCT06687265","phase":"PHASE2","title":"Effects of Metformin on Hepatic Venous Pressure Gradient in Patients With Cirrhosis and Portal Hypertension","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-03-10","conditions":"Cirrhosis, Portal Hypertension Related to Cirrhosis","enrollment":76},{"nctId":"NCT01905046","phase":"PHASE3","title":"Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2015-11-23","conditions":"Atypical Ductal Breast Hyperplasia, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier","enrollment":86},{"nctId":"NCT06829238","phase":"PHASE4","title":"Assessment of Metformin for Restoration of Immune Homeostasis in HIV+ and HIV- Individuals With a History of Injection Drug Use","status":"RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2025-04-07","conditions":"Systemic Inflammation, Immune Dysregulation, Injection Drug Use","enrollment":100},{"nctId":"NCT06033131","phase":"PHASE3","title":"PI4 - A Trial Assessing Metformin to Prolong Gestation in Preterm Preeclampsia","status":"RECRUITING","sponsor":"Lina Bergman","startDate":"2024-01-19","conditions":"Preeclampsia","enrollment":294},{"nctId":"NCT06000462","phase":"PHASE4","title":"The Effect of Dapagliflozin on Weight Loss in Obese Adults Without Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Oman Ministry of Health","startDate":"2024-04-22","conditions":"Obesity, Dapagliflozin Adverse Reaction, Weight Loss","enrollment":150},{"nctId":"NCT04979130","phase":"PHASE4","title":"Comparing Semaglutide Versus Placebo on Intestinal Barrier Function in Type 2 Diabetes Mellitus (SIB)","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2022-01-01","conditions":"Type 2 Diabetes, Chronic Inflammation, Intestinal Permeability","enrollment":69},{"nctId":"NCT02980276","phase":"PHASE3","title":"RCT Metformin for Reduction of Gestational Diabetes Mellitus Effects","status":"COMPLETED","sponsor":"National University of Ireland, Galway, Ireland","startDate":"2017-06-06","conditions":"Gestational Diabetes","enrollment":535},{"nctId":"NCT06860841","phase":"PHASE4","title":"Effects of D-Chiro-Inositol Combined with Metformin on Insulin Resistance in People with Overweight or Obesity and T2DM","status":"ACTIVE_NOT_RECRUITING","sponsor":"Campus Bio-Medico University","startDate":"2025-01-10","conditions":"Type 2 Diabetes, Overweight and Obese Adults","enrollment":16},{"nctId":"NCT03629340","phase":"PHASE2","title":"Metformin for Pulmonary Hypertension HFpEF","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2019-02-26","conditions":"Pulmonary Hypertension, Heart Failure","enrollment":10},{"nctId":"NCT05689684","phase":"NA","title":"Arabinoxylan-oligosaccharides (AXOS) for the Management of Type-2 Diabetes","status":"COMPLETED","sponsor":"Lund University","startDate":"2022-11-07","conditions":"Diabetes Type 2","enrollment":66},{"nctId":"NCT04055012","phase":"PHASE2","title":"Effects of Metformin on Low Back Pain","status":"TERMINATED","sponsor":"Gwendolyn Sowa","startDate":"2020-01-07","conditions":"Low Back Pain","enrollment":23},{"nctId":"NCT05120505","phase":"PHASE4","title":"Metformin in Children With Fragile X Syndrome","status":"RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2021-12-29","conditions":"Fragile X Syndrome, Metformin","enrollment":20},{"nctId":"NCT03651895","phase":"PHASE2","title":"Metformin to Reduce Airway Glucose in COPD Patients","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2022-05-17","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":14},{"nctId":"NCT03047837","phase":"PHASE2","title":"A Randomized, 2x2 Factorial Design Biomarker Prevention Trial of Low-dose ASA and Metformin in Stage I-III Crc Patients","status":"TERMINATED","sponsor":"Ente Ospedaliero Ospedali Galliera","startDate":"2017-03-15","conditions":"Tertiary Prevention in Colon Cancer","enrollment":160},{"nctId":"NCT05504226","phase":"PHASE3","title":"Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin 25 mg and Metformin","status":"COMPLETED","sponsor":"Handok Inc.","startDate":"2022-10-12","conditions":"Type 2 Diabetes","enrollment":214},{"nctId":"NCT05504239","phase":"PHASE3","title":"Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin and Metformin","status":"COMPLETED","sponsor":"Handok Inc.","startDate":"2022-09-27","conditions":"Type 2 Diabetes","enrollment":235},{"nctId":"NCT03479476","phase":"PHASE2, PHASE3","title":"A Trial of Metformin in Individuals With Fragile X Syndrome","status":"COMPLETED","sponsor":"University of California, Davis","startDate":"2018-04-30","conditions":"Fragile X Syndrome, Fragile X Mental Retardation Syndrome, Mental Retardation, X Linked","enrollment":120},{"nctId":"NCT06762223","phase":"PHASE4","title":"Henagliflozin on Liver Fibrosis in Patients with MASLD and T2DM","status":"NOT_YET_RECRUITING","sponsor":"Xiqiao Zhou","startDate":"2024-12-31","conditions":"Metabolic Dysfunction-associated Steatotic Liver Disease, Type 2 Diabetes Mellitus","enrollment":190},{"nctId":"NCT05345327","phase":"PHASE3","title":"SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 Diabetes","status":"RECRUITING","sponsor":"The George Institute","startDate":"2023-01-01","conditions":"Type 2 Diabetes","enrollment":994},{"nctId":"NCT02049034","phase":"PHASE4","title":"Lixisenatide-The Effects on Glucose and Lipid Metabolism in Type 2 Diabetes","status":"COMPLETED","sponsor":"University of Surrey","startDate":"2014-01","conditions":"Type 2 Diabetes","enrollment":8},{"nctId":"NCT02514629","phase":"PHASE3","title":"Testosterone, Metformin, or Both, for Hypogonadism in Obese Males","status":"COMPLETED","sponsor":"Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud","startDate":"2013-07-04","conditions":"Hypogonadism, Obesity","enrollment":107},{"nctId":"NCT04998032","phase":"PHASE2, PHASE3","title":"A Study of Efficacy and Safety of Supaglutide in Type 2 Diabetes Patients On Metformin Treatment(SUPER-2)","status":"COMPLETED","sponsor":"Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.","startDate":"2021-10-12","conditions":"Type2 Diabetes","enrollment":620},{"nctId":"NCT03618472","phase":"NA","title":"Comparison of the Effectiveness Metformin for Deceasing Proliferative Marker in Endometrial Cancer Cells","status":"COMPLETED","sponsor":"Department of Medical Services Ministry of Public Health of Thailand","startDate":"2018-07-01","conditions":"Metformin, CA Endometrium","enrollment":50},{"nctId":"NCT06005142","phase":"NA","title":"Therapeutic Intervention of Eriomin Associated with Metformin in the Control of Hyperglycemia in Pre-Diabetic Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Thais Cesar","startDate":"2024-01-15","conditions":"Pre-diabetes","enrollment":80},{"nctId":"NCT03031821","phase":"PHASE3","title":"Metformin in Patients Initiating ADT as Prevention and Intervention of Metabolic Syndrome","status":"TERMINATED","sponsor":"Canadian Urologic Oncology Group","startDate":"2018-07-12","conditions":"Prostate Cancer, Metabolic Syndrome","enrollment":168},{"nctId":"NCT06318442","phase":"NA","title":"The GAPSID Study - How GLP-1 Analogues Prevent Steroid-Induced Diabetes","status":"RECRUITING","sponsor":"Imperial College London","startDate":"2024-05-15","conditions":"Steroid-Induced Diabetes, Steroid Induced Hyperglycemia","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["placebo"],"phase":"marketed","status":"active","brandName":"Placebo (for metformin)","genericName":"Placebo (for metformin)","companyName":"Seoul National University Hospital","companyId":"seoul-national-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A placebo has no active pharmacological mechanism; it produces therapeutic effects through psychological and physiological expectation rather than direct drug action. Used for Control comparator in metformin clinical trial.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}